Michael Elliott Weinblatt MD

Michael E. Weinblatt earned a medical degree at the University of Maryland School of Medicine in Baltimore, where he also completed his internship and residency. He completed a clinical fellowship in rheumatology at the Robert B. Brigham Hospital, Harvard Medical School. Dr. Weinblatt was a member of the Rheumatology Subspecialty Board of the American Board of Internal Medicine from 1994 to 2000 and he served as the President of the American College of Rheumatology in 2001.

Dr. Weinblatt is the author of The Arthritis Action Program: An Integrated Plan of Traditional and Complementary Therapies. He has also authored or co-authored more than 180 published papers, reviews, and book chapters on rheumatology. Additionally, he is the co-editor of Targeted Treatment of Rheumatic Diseases and the textbook Rheumatology (3rd, 4th, and 5th editions).

His major research interest is in the therapeutics for rheumatoid arthritis, which includes studies of methotrexate and biologic response modifiers. His work on the development of methotrexate therapy for rheumatoid arthritis garnered him the Carol Nachman Prize for Rheumatology and the Arthritis Foundation’s Virginia P. Engalitcheff Award for Impact on Quality of Life. In 2008, Dr. Weinblatt received the American College of Rheumatology Distinguished Clinical Investigator Award.